To further assess the relevance of c-Jun phosphorylation and CPT1A expression on the clinical outcomes of ER-positive BC patients, we assessed and quantified the expression of Ser-63-phosphorylated c-Jun and CPT1A by immunohistochemistry in ER-positive BC tissues. This evidence concerns the gene CPT1A and breast cancer.